These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 24108526)

  • 21. Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.
    Wang Z; Wu Q; Nie X; Guo J; Yang C
    Clin Drug Investig; 2015 Nov; 35(11):707-16. PubMed ID: 26387030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The value of maximal rate of left ventricular pressure in evaluating cardiac function in patients with sepsis-induced cardiomyopathy].
    Wang J; He Z; Gao X; Wang Z; Yin C; Li T
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jun; 35(6):620-626. PubMed ID: 37366129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock.
    Morelli A; Donati A; Ertmer C; Rehberg S; Kampmeier T; Orecchioni A; Di Russo A; D'Egidio A; Landoni G; Lombrano MR; Botticelli L; Valentini A; Zangrillo A; Pietropaoli P; Westphal M
    Crit Care; 2011; 15(5):R217. PubMed ID: 21929764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock.
    Hernández G; Tapia P; Alegría L; Soto D; Luengo C; Gomez J; Jarufe N; Achurra P; Rebolledo R; Bruhn A; Castro R; Kattan E; Ospina-Tascón G; Bakker J
    Crit Care; 2016 Aug; 20(1):234. PubMed ID: 27480413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock.
    Wei C; Louis H; Schmitt M; Albuisson E; Orlowski S; Levy B; Kimmoun A
    Crit Care; 2016 Dec; 20(1):407. PubMed ID: 27998289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The β-Blocker Esmolol Restores the Vascular Waterfall Phenomenon After Acute Endotoxemia.
    Du W; Liu D; Long Y; Wang X
    Crit Care Med; 2017 Dec; 45(12):e1247-e1253. PubMed ID: 28991824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Propofol and Dexmedetomidine Sedation on Norepinephrine Requirements in Septic Shock Patients: A Crossover Trial.
    Morelli A; Sanfilippo F; Arnemann P; Hessler M; Kampmeier TG; D'Egidio A; Orecchioni A; Santonocito C; Frati G; Greco E; Westphal M; Rehberg SW; Ertmer C
    Crit Care Med; 2019 Feb; 47(2):e89-e95. PubMed ID: 30394918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial.
    Er F; Dahlem KM; Nia AM; Erdmann E; Waltenberger J; Hellmich M; Kuhr K; Le MT; Herrfurth T; Taghiyev Z; Biesenbach E; Yüksel D; Eran-Ergöknil A; Vanezi M; Caglayan E; Gassanov N
    JACC Cardiovasc Interv; 2016 Feb; 9(3):231-240. PubMed ID: 26847114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study.
    Albanèse J; Leone M; Delmas A; Martin C
    Crit Care Med; 2005 Sep; 33(9):1897-902. PubMed ID: 16148457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systolic-dicrotic notch pressure difference can identify tachycardic patients with septic shock at risk of cardiovascular decompensation following pharmacological heart rate reduction.
    Morelli A; Romano SM; Sanfilippo F; Santonocito C; Frati G; Chiostri M; Agrò FE; Ertmer C; Rehberg SW; Vieillard-Baron A
    Br J Anaesth; 2020 Dec; 125(6):1018-1024. PubMed ID: 32690246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esmolol reduces anesthetic requirements thereby facilitating early extubation; a prospective controlled study in patients undergoing intracranial surgery.
    Asouhidou I; Trikoupi A
    BMC Anesthesiol; 2015 Nov; 15():172. PubMed ID: 26615516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful management of persistent tachycardia using esmolol in 2 dogs with septic shock.
    Beer KS; Balakrishnan A; Hart SK
    J Vet Emerg Crit Care (San Antonio); 2019 May; 29(3):326-330. PubMed ID: 31044499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esmolol infusion in patients with septic shock and tachycardia: a prospective, single-arm, feasibility study.
    Brown SM; Beesley SJ; Lanspa MJ; Grissom CK; Wilson EL; Parikh SM; Sarge T; Talmor D; Banner-Goodspeed V; Novack V; Thompson BT; Shahul S;
    Pilot Feasibility Stud; 2018; 4():132. PubMed ID: 30123523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
    Barton P; Garcia J; Kouatli A; Kitchen L; Zorka A; Lindsay C; Lawless S; Giroir B
    Chest; 1996 May; 109(5):1302-12. PubMed ID: 8625683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of intravenous esmolol for cardiac protection in non-cardiac surgery. A systematic review and meta-analysis.
    Ollila A; Vikatmaa L; Sund R; Pettilä V; Wilkman E
    Ann Med; 2019 Feb; 51(1):17-27. PubMed ID: 30346213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The impacts of low-dose corticosteroids infusion given in different manners on refractory septic shock patients].
    Chen Z; Yang C; He H; He Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):443-7. PubMed ID: 26049181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esmolol before cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial.
    Bignami E; Guarnieri M; Franco A; Gerli C; De Luca M; Monaco F; Landoni G; Zangrillo A
    Perfusion; 2017 May; 32(4):313-320. PubMed ID: 27932571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic Effects, Safety, and Feasibility of Intravenous Esmolol Infusion During Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction: Results From A Multicenter Registry.
    Santoro F; Ieva R; Ferraretti A; Fanelli M; Musaico F; Tarantino N; Martino LD; Gennaro LD; Caldarola P; Biase MD; Brunetti ND
    Cardiovasc Ther; 2016 Jun; 34(3):161-6. PubMed ID: 26946520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial.
    Whitehouse T; Hossain A; Perkins GD; Gordon AC; Bion J; Young D; McAuley D; Singer M; Lord J; Gates S; Veenith T; MacCallum NS; Yeung J; Innes R; Welters I; Boota N; Skilton E; Ghuman B; Hill M; Regan SE; Mistry D; Lall R;
    JAMA; 2023 Nov; 330(17):1641-1652. PubMed ID: 37877587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.